{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T19:54:58Z","timestamp":1762458898228,"version":"build-2065373602"},"reference-count":26,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"vor","delay-in-days":1553,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Australian and New Zealand Journal of Public Health"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1111\/j.1753-6405.2011.00743.x","type":"journal-article","created":{"date-parts":[[2011,9,12]],"date-time":"2011-09-12T07:58:36Z","timestamp":1315814316000},"page":"421-426","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Higher HCV antibody prevalence among Indigenous clients of needle and syringe programs"],"prefix":"10.1016","volume":"35","author":[{"given":"James","family":"Ward","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Libby","family":"Topp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jenny","family":"Iversen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Handan","family":"Wand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Snehal","family":"Akre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Kaldor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Maher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/j.1753-6405.2011.00743.x_b1","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1136\/sti.2004.009423","article-title":"Screening injecting drug users for sexually transmitted infections and blood borne viruses using street outreach and self collected sampling","volume":"81","author":"Bradshaw","year":"2005","journal-title":"Sex Transm Infect"},{"year":"2002","series-title":"Return on Investment in Needle and Syringe Programs in Australia","key":"10.1111\/j.1753-6405.2011.00743.x_b2"},{"year":"2009","series-title":"Return on Investment 2: Evaluating the Cost-effectiveness of Needle and Syringe Programs in Australia 2009","key":"10.1111\/j.1753-6405.2011.00743.x_b3"},{"key":"10.1111\/j.1753-6405.2011.00743.x_b4","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1111\/j.1440-1746.2004.03438.x","article-title":"Risk behaviours and antibody hepatitis B and C prevalence among injecting drug users in south-western Sydney, Australia","volume":"19","author":"Maher","year":"2004","journal-title":"J Gastroenterol Hepatol"},{"year":"2009","series-title":"Bloodborne viral and Sexually Transmitted Infections in Aboriginal and Torres Strait Islander People: Surveillance and Evaluation Report","key":"10.1111\/j.1753-6405.2011.00743.x_b5"},{"year":"2009","series-title":"HIV\/AIDS, Viral Hepatitis and Sexually Transmissible Infections in Australia. Annual Surveillance Report","key":"10.1111\/j.1753-6405.2011.00743.x_b6"},{"year":"2006","series-title":"Hepatitis C Virus Projections Working Group: Estimates and Projections of the Hepatitis C Virus Epidemic in Australia 2006","key":"10.1111\/j.1753-6405.2011.00743.x_b7"},{"year":"2010","series-title":"Third National Hepatitis C Strategy 2010\u20132013","key":"10.1111\/j.1753-6405.2011.00743.x_b8"},{"key":"10.1111\/j.1753-6405.2011.00743.x_b9","doi-asserted-by":"crossref","first-page":"237","DOI":"10.5694\/j.1326-5377.1997.tb140102.x","article-title":"HIV prevalence and risk behaviour in needle exchange attenders: a national study","volume":"166","author":"MacDonald","year":"1997","journal-title":"Med J Aust"},{"key":"10.1111\/j.1753-6405.2011.00743.x_b10","doi-asserted-by":"crossref","first-page":"57","DOI":"10.5694\/j.1326-5377.2000.tb139199.x","article-title":"Hepatitis C virus antibody prevalence among injecting drug users at selected needle and syringe programs in Australia, 1995\u20131997","volume":"172","author":"MacDonald","year":"2000","journal-title":"Med J Aust"},{"key":"10.1111\/j.1753-6405.2011.00743.x_b11","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1111\/j.1360-0443.2006.01543.x","article-title":"Incidence and risk factors for hepatitis C seroconversion in injecting drug users in Australia","volume":"101","author":"Maher","year":"2006","journal-title":"Addiction"},{"issue":"3","key":"10.1111\/j.1753-6405.2011.00743.x_b12","doi-asserted-by":"crossref","first-page":"253","DOI":"10.17730\/humo.63.3.h1phxbhrb7m4mlv0","article-title":"The everyday violence of hepatitis C among young women who inject drugs in San Francisco","volume":"63","author":"Bourgois","year":"2004","journal-title":"Human Organization"},{"issue":"3","key":"10.1111\/j.1753-6405.2011.00743.x_b13","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/QAI.0b013e318160d5ae","article-title":"Individual, social, and environmental influences associated with HIV infection among injection drug users in Tijuana, Mexico","volume":"47","author":"Strathdee","year":"2008","journal-title":"Journal of Acquired Immune Deficiency Syndrome"},{"year":"2004","series-title":"Increasing Access to Services in NSW for Aboriginal People at Risk of Contracting or Who have Blood Borne Infections","key":"10.1111\/j.1753-6405.2011.00743.x_b14"},{"year":"2008","series-title":"National Prison Entrants\u2019 Bloodborne Virus and Risk Behaviour Survey Report 2004 & 2007","author":"Butler","key":"10.1111\/j.1753-6405.2011.00743.x_b15"},{"year":"2011","series-title":"Report on Government Services 2011","key":"10.1111\/j.1753-6405.2011.00743.x_b16"},{"year":"2004","series-title":"Supply, Demand and Harm Reduction Strategies in Australian Prisons: Implementation, Cost and Evaluation","author":"Black","key":"10.1111\/j.1753-6405.2011.00743.x_b17"},{"key":"10.1111\/j.1753-6405.2011.00743.x_b18","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jinf.2009.02.014","article-title":"Markers and risk factors for HCV, HBV and HIV in a network of injecting drug users in Melbourne, Australia","volume":"58","author":"Miller","year":"2009","journal-title":"J Infect"},{"key":"10.1111\/j.1753-6405.2011.00743.x_b19","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/s11524-008-9330-7","article-title":"Hepatitis C virus acquisition among injecting drug users: a cohort analysis of a national repeated cross-sectional survey of needle and syringe program attendees in Australia, 1995\u20132004","volume":"86","author":"Falster","year":"2009","journal-title":"J Urban Health"},{"key":"10.1111\/j.1753-6405.2011.00743.x_b20","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.drugpo.2003.10.006","article-title":"Hepatitis C and incarcerated populations","volume":"15","author":"Macalino","year":"2004","journal-title":"Int J Drug Policy"},{"key":"10.1111\/j.1753-6405.2011.00743.x_b21","first-page":"165","article-title":"Estimates of HIV prevalence and Incidence in Canada, 2005","volume":"32","author":"Boulos","year":"2006","journal-title":"Can Commun Dis Rep"},{"key":"10.1111\/j.1753-6405.2011.00743.x_b22","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1097\/QAI.0b013e31816a1d68","article-title":"Representativeness of injecting drug users who participate in HIV surveillance results from Australia's Needle and Syringe Program Survey","volume":"47","author":"Topp","year":"2008","journal-title":"Journal of Acquired Immune Deficiency Syndrome"},{"key":"10.1111\/j.1753-6405.2011.00743.x_b23","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.annepidem.2004.09.004","article-title":"Modelling sources of self-report bias in a survey of drug use epidemiology","volume":"15","author":"Johnson","year":"2005","journal-title":"Ann Epidemiol"},{"key":"10.1111\/j.1753-6405.2011.00743.x_b24","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/j.1360-0443.1993.tb02058.x","article-title":"Socially desirable responding and self-reported HIV infection risk behaviours among intravenous drug users","volume":"88","author":"Latkin","year":"1993","journal-title":"Addiction"},{"key":"10.1111\/j.1753-6405.2011.00743.x_b25","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/S0376-8716(98)00028-3","article-title":"Self-report among injecting drug users: a review","volume":"51","author":"Darke","year":"1998","journal-title":"Drug Alcohol Depend"},{"key":"10.1111\/j.1753-6405.2011.00743.x_b26","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1080\/09540120701192837","article-title":"Self reported drug use and risk behaviour among injecting drug users: self versus assisted questionnaire completion","volume":"19","author":"White","year":"2007","journal-title":"AIDS Care"}],"container-title":["Australian and New Zealand Journal of Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1753-6405.2011.00743.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1753-6405.2011.00743.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1326020023017727?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1326020023017727?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1753-6405.2011.00743.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:26:18Z","timestamp":1761157578000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1326020023017727"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S1326020023017727"],"URL":"https:\/\/doi.org\/10.1111\/j.1753-6405.2011.00743.x","relation":{},"ISSN":["1326-0200"],"issn-type":[{"type":"print","value":"1326-0200"}],"subject":[],"published":{"date-parts":[[2011,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Higher HCV antibody prevalence among Indigenous clients of needle and syringe programs","name":"articletitle","label":"Article Title"},{"value":"Australian and New Zealand Journal of Public Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1753-6405.2011.00743.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright 2011 THE AUTHORS.","name":"copyright","label":"Copyright"}]}}